Literature DB >> 1430153

Multiple sclerosis and vitamin B12 metabolism.

E H Reynolds1.   

Abstract

Multiple sclerosis (MS) is occasionally associated with vitamin B12 deficiency. Recent studies have shown an increased risk of macrocytosis, low serum and/or CSF vitamin B12 levels, raised plasma homocysteine and raised unsaturated R-binder capacity in MS. The aetiology of the vitamin B12 deficiency in MS is often uncertain and a disorder of vitamin B12 binding or transport is suspected. The nature of the association of vitamin B12 deficiency and MS is unclear but is likely to be more than coincidental. There is a remarkable similarity in the epidemiology of MS and pernicious anaemia. Vitamin B12 deficiency should always be looked for in MS. The deficiency may aggravate MS or impair recovery. There is evidence that vitamin B12 is important for myelin synthesis and integrity but further basic studies are required.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430153     DOI: 10.1016/0165-5728(92)90137-a

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.

Authors:  S J van Rensburg; M J Kotze; D Hon; P Haug; J Kuyler; M Hendricks; J Botha; F C V Potocnik; T Matsha; R T Erasmus
Journal:  Metab Brain Dis       Date:  2006-05-26       Impact factor: 3.584

2.  Cognitive Impairment in Patients with Multiple Sclerosis.

Authors:  Hakan Akgün; Mehmet Yücel; Oğuzhan Öz; Şeref Demirkaya
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

3.  Characterization of phospholipid methylation in rat brain myelin.

Authors:  V Tsvetnitsky; L Auchi; A Nicolaou; W A Gibbons
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

Review 4.  [Diet and multiple sclerosis].

Authors:  S Schwarz; H Leweling
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

Review 5.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 6.  The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.

Authors:  T Bottiglieri; K Hyland; E H Reynolds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

Review 7.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

8.  Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?

Authors:  Mohamad Reza Najafi; Vahid Shaygannajad; Maryam Mirpourian; Ali Gholamrezaei
Journal:  Int J Prev Med       Date:  2012-04

Review 9.  Multiple sclerosis.

Authors:  Alan Gaby
Journal:  Glob Adv Health Med       Date:  2013-01

10.  Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study.

Authors:  Amanda K Irish; Constance M Erickson; Terry L Wahls; Linda G Snetselaar; Warren G Darling
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.